Structure |
Chemical Name |
CAS |
MF |
|
methyl (4-(5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-2-methylbenzoyl)glycinate |
864731-38-4 |
C21H17Cl2F3N2O4 |
|
4-HYDROXY-7-METHYLCOUMARIN |
18692-77-8 |
C10H8O3 |
|
Tripropargyl benzene-1,3,5-tricarboxylate |
871830-29-4 |
C18H12O6 |
|
Larotaxel intermediate(A-3) |
156294-33-6 |
C31H36O10 |
|
8-isopropyl-4-methyl- 2H-chromen-2-one |
923019-31-2 |
C13H14O2 |
|
(3R,5S,2R,3S)-posaconazole |
|
|
|
BENZYL 3-PYRROLINE-1-CARBOXYLATE |
31970-04-4 |
C12H13NO2 |
|
ethyl 2-(methylthio)indolizine-3-carboxylate |
123471-45-4 |
C12H13NO2S |
|
benzyl (S)-2-(2,2,2-trifluoroethyl)piperazine-1-carboxylate |
|
|
|
Flomoxef Intermediate OXA |
|
|
|
NA |
|
|
|
Selamectin |
220119-17-5 |
C43H63NO11 |
|
4-Methoxy-3-(3-methoxypropoxy)benzenemethanol |
172900-74-2 |
C12H18O4 |
|
2,2-DIMETHYLCYANOACETATE METHYL ESTER |
72291-30-6 |
C6H9NO2 |
|
8H-7,10-Methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-diMethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-Methoxy-3,6-dioxo-, Methyl ester, (1aR,5S,8S,10R,22aR)- |
1206524-84-6 |
C30H40N4O7 |
|
6,11-dihydro-11-oxo-dibenz[b,e]oxepin-2-acetate,methyl ester |
55689-64-0 |
C17H14O4 |
|
Vilanterol |
503068-34-6 |
C24H33Cl2NO5 |
|
(4S)-(2,2-dimethyl-1,3-dioxolan-4-yl)-3-(4- hydroxybenzene) propanoic acid,methyl ester (Landiolol) |
144256-11-1 |
C15H20O5 |
|
{4-[(4-fluorobenzil)aMMino]-2-nitrofenil}carbaMMato di etile |
150812-23-0 |
C16H16FN3O4 |
|
N-{3-[5-(2-chloro-4-pyriMidinyl)-2-(1,1-diethylethyl)-1,3-thiazol-4-yl]-2-fluoraphenyl}-2,6-difluorobenzenesulfonaMide |
1195768-23-0 |
C23H18ClF3N4O2S2 |
|
(S)-5-methoxy-1,2,3,4-tetrahydro-N-(phenylmethyl)- 2-Naphthalenamine (Rotigotine) |
58349-23-8 |
C18H21NO |
|
5-methoxy-1,2,3,4-tetrahydro-N-(phenylmethyl)- 2-Naphthalenamine (Rotigotine) |
136247-07-9 |
C18H21NO |
|
N-Methyl-N-(naphtha-1-yleMnthyl)-aMMoniuM-acetate |
|
|
|
5-Chloro-2-hydroxy-3-nitro-(1,1-biphenyl)-3-carboxylic acid |
376592-58-4 |
C13H8ClNO5 |
|
(4R,12aS)-7-(benzyloxy)-9-broMo-4-Methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione |
1206102-10-4 |
C19H19BrN2O4 |
|
Aliskiren inter-11 |
387353-77-7 |
C9H15ClO2 |
|
1-benzyl-4-methylpiperidin-3-ol |
384338-20-9 |
C13H19NO |
|
4-hydroxy-N,N-diphenyl-(4R)-2-Pentynamide |
899809-61-1 |
C17H15NO2 |
|
Vilanterol Trifenatate |
503070-58-4 |
C44H49Cl2NO7 |
|
2,6-Dichloro-3,5-dimethoxyaniline |
872509-56-3 |
C8H9Cl2NO2 |
|
(S)-3,3-Dimethyl-2-((1R,2R)-2-pent-4-ynyl-cyclopropoxycarbonylamino)-butyric acid, tert-butylamine salt |
1425038-21-6 |
C19H34N2O4 |
|
methyl (33R,35S,91R,92R,5S,Z)-5-(tert-butyl)-17-methoxy-4,7-dioxo-2,8-dioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopropanacyclotetradecaphan-12-yne-35-carboxylate |
1425038-23-8 |
C30H36N4O7 |
|
3'-AMINO-BIPHENYL-3-CARBOXYLIC ACID METHYL ESTER |
168619-25-8 |
C14H13NO2 |
|
Methyl-2,3-O-isopropylidene-D-ribofuranoside |
72402-14-3 |
C9H16O5 |
|
8-Benzyl-3-exo-(5-isopropyl-3-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane |
423165-13-3 |
C20H28N4 |
|
6-aMino-3-cyclopropyl-1-(2-fluoro-4-iodophenyl)pyriMidine-2,4(1H,3H)-dione |
871700-28-6 |
C13H11FIN3O2 |
|
2-CHLORO-1,3-DIMETHYLAMINO TRIMETHINIUM HEXAFLUOROPHOSPHATE |
291756-76-8 |
C7H14ClF6N2P |
|
2,2-Dimethylthiopropionamide |
630-22-8 |
C5H11NS |
|
Benzaldehyde, 4-methoxy-3-(3-methoxypropoxy)- |
172900-75-3 |
C12H16O4 |
|
2,7-DibroMo-9,9-difluoro-9H-fluorene |
1229603-71-7 |
C13H6Br2F2 |
|
(6S)-6-[5-[7-[2-(1R,3S,4S)-2-Azabicyclo[2.2.1]hept-3-yl-1H-benzimidazol-6-yl]-9,9-difluoro-9H-fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane hydrochloride (1:4) |
1499193-67-7 |
C35H33ClF2N6 |
|
Ethanol, 2-[(2,6-dichlorophenyl)Methoxy]- |
85309-91-7 |
C9H10Cl2O2 |
|
3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6-(MethylaMino)pyriMidine-2,4(1H,3H)-dione |
871700-22-0 |
C14H13FIN3O2 |
|
Dabrafenib Mesylate |
1195768-06-9 |
C24H24F3N5O5S3 |
|
Phosphonic acid, [[5-(3-fluorophenyl)-2-pyridinyl]Methyl]-, diethyl ester |
380894-77-9 |
C16H19FNO3P |
|
2,2'-dithiobis[N-methylbenzamide] |
2527-58-4 |
C16H16N2O2S2 |
|
(S)-1,2,3,4-tetrahydro-5-methoxy-N-propyl-2-Naphthalenamine(Rotigotine) |
101403-24-1 |
C14H21NO |
|
7-Amino-8-oxo-3-(cis-prop-1-enyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid diphenylmethyl ester hydrochloride |
106447-41-0 |
C23H22N2O3S |
|
2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one |
283173-80-8 |
C11H8BrFN2O |
|
8-FLUORO-3-IODOQUINOLINE |
866782-59-4 |
C9H5FIN |
|
2-(4-MESYLPHENYL)-1-(6-METHYLPYRIDIN-3-YL)- ETHAN-1-ONE |
221615-75-4 |
C15H15NO3S |
|
GSK1120212 (DMSO solvate) |
1187431-43-1 |
C28H29FIN5O5S |
|
(4R,12aS)-N-(2,4-difluorobenzyl)-7-benzylhydroxy-4-Methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxaMide |
1206102-11-5 |
C27H25F2N3O5 |
|
Methyl 3-(2,6-difluorophenylsulfonamido)-2-fluorobenzoate |
1195768-19-4 |
C14H10F3NO4S |
|
Axitinib Impurity B |
944835-85-2 |
C15H13N3OS |
|
(1R,3aR,4aR,8aR,9S,9aR)-1-methyl-3-oxodecahydro-3H-spiro[naphtho[2,3-c]furan-6,2'-[1,3]dioxolane]-9-carboxylic acid |
900161-13-9 |
C17H25NO6 |
|
1-(3,4-DiMethoxy-phenyl)-3-Methyl-butan-1-one |
132858-47-0 |
C13H18O3 |
|
2-ethyl-4-(4-Methyl-1-piperazinyl)- 10H-Thieno[2,3-b][1,5]benzodiazepine |
61325-71-1 |
C18H22N4S |
|
N-(3-(3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-diMethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyriMidin-5-ylaMino)phenyl)acetaMide |
871700-25-3 |
C26H23FIN5O4 |
|
PyridaziniuM, 1-aMino-, iodide (1:1) |
35073-04-2 |
C4H6IN3 |
|
2-Propenoic acid, 3-(5-nitro-1-cyclohexen-1-yl)-, (1R)-4-(diphenylaMino)-1-Methyl-4-oxo-2-butyn-1-yl ester, (2E)- |
899809-60-0 |
C26H24N2O5 |
|
Ledipasvir Intermediate N-2 |
|
|
|
2-{Hydroxy-[4-Methoxy-3-(3-Methoxy-propoxy)-phenyl]-Methyl}-3-Methyl-butyric acid Methyl ester |
|
C18H28O6 |
|
(3-exo)-8-Methyl-8-azabicyclo[3.2.1]octane-3-thiol hydrochloride |
1141886-66-9 |
C8H15NS.HCl |
|
Methyl 3-(benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylate |
1206102-07-9 |
C17H19NO6 |
|
1-Aminoindan sulfate (Rasagiline) |
936474-09-8 |
2(C9H11N).H2SO4 |
|
N-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)acetamide (Tamibarotene) |
139162-43-9 |
C16H23NO |
|
2-[4-Methoxy-3-(3-Methoxy-propoxy)-benzoyl]-3-Methyl-butyric acid Methyl ester |
|
C18H26O6 |
|
3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-diMethylpyrido[2,3-d]pyriMidine-2,4,7(1H,3H,8H)-trione |
871700-24-2 |
C18H15FIN3O4 |
|
8-fluoro-3-(phenylsulfonyl)- Quinoline |
866782-60-7 |
C15H10FNO2S |
|
952680-40-9 |
952680-40-9 |
|
|
2-Cyano-2,2-diMethyl-acetaMide |
|
C5H8N2O |
|
(E)-2-chloro-3-iMino-N,N-diMethylprop-1-en-1-aMine hydrochloride |
1352804-27-3 |
C5H10Cl2N2 |
|
Methyl 3-(benzyloxy)-1-(2,2-dihydroxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate |
1206102-08-0 |
C16H17NO6 |
|
1-(2,2-diMethoxyethyl)-5-Methoxy-6-(Methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid |
1335210-23-5 |
C13H17NO8 |
|
(R)-2-((S)-2,2-diMethyl-5-oxo-1,3-dioxolan-4-yl)-3-(naphthalen-2-yl)propanoic acid |
198568-07-9 |
C18H18O5 |
|
N-{3-[(2-chloro-4-pyriMidinyl)acetyl]-2-fluorophenyl}-2,6-difluorobenzenesulfonaMide |
|
C18H11ClF3N3O3S |
|
4-Morpholinecarboxamide, N-(2-aminoethyl)-, ethanedioate (Landiolol) |
947674-94-4 |
C9H17N3O6 |
|
(S)-4-Benzyl-3-((S)2-((R) -2-BroMo-2((2S,4S)-4-isopropyl-5-
oxo-tetrahydro-furan-2-yl)-3-Methyl-butyryl)-oxaxolidin-2-one |
173154-00-2 |
C24H32BrNO5 |
|
(R)-4-Propyldihydrofuran-2(3H)-one |
63095-51-2 |
C7H12O2 |
|
(4R,12aS)-7-(benzyloxy)-4-Methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione |
1206102-09-1 |
C19H20N2O4 |
|
DiMethyl 3-(benzyloxy)-1-(2,2-diMethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate |
1357289-08-7 |
C20H23NO8 |
|
(3R,3aS,4S,4aS,7R,9aR)-3-Methyl-7-nitro-1-oxo-N,N-diphenyl-1,3,3a,4,4a,5,6,7,8,9a-decahydronaphtho[2,3-c]furan-4-carboxamide |
900186-72-3 |
C26H26N2O5 |